HOOKIPA Pharma Inc. announced the appointment of Tim Reilly, Ph.D. to its Board of Directors, effective immediately. Tim currently serves as Chief Development Officer at HotSpot Therapeutics. Prior to taking this role in 2021, Tim spent more than 18 years at Bristol Myers Squibb (BMS).

He last served as Senior Vice President within Research & Early Development, where he was responsible for the early development portfolio across therapeutic areas in oncology, immunology, fibrosis, cardiovascular and neuroscience.